For Type 2 Diabetes Poorly Controlled by Metformin Monotherapy, the Addition of Any Non-Insulin Antidiabetic Drug Reduces HbA1c to a Similar Extent, but With Differing Effects on Weight and Hypoglycaemic Risk

Evidence-Based Medicine - United Kingdom
doi 10.1136/ebm1116
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ


Related search